BIO 2013: Biosimilars, Drug Pricing, Business Development And Innovation
Executive Summary
Pharma and biotech leaders discussed the biosimilars landscape, paying for innovation beyond rare disease drugs, emerging markets and partnering trends at BIO 2013 in Chicago.